These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19299748

  • 1. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
    Chiron D, Pellat-Deceunynck C, Amiot M, Bataille R, Jego G.
    J Immunol; 2009 Apr 01; 182(7):4471-8. PubMed ID: 19299748
    [Abstract] [Full Text] [Related]

  • 2. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, Kuga H, Odaka M, Suzuki S, Watanabe S, Takeuchi H, Kasama T, Adachi M.
    Clin Exp Allergy; 2006 Aug 01; 36(8):1049-62. PubMed ID: 16911361
    [Abstract] [Full Text] [Related]

  • 3. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y, An H, Yao M, Hou J, Yu Y, Feng G, Cao X.
    J Immunol; 2010 Jun 01; 184(11):6447-56. PubMed ID: 20435932
    [Abstract] [Full Text] [Related]

  • 4. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Masuya M, Horie R, Uchida K, Takei Y.
    Int J Oncol; 2008 Nov 01; 33(5):929-36. PubMed ID: 18949355
    [Abstract] [Full Text] [Related]

  • 5. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q, Wei H, Tian Z.
    BMC Cancer; 2008 Jan 17; 8():12. PubMed ID: 18199340
    [Abstract] [Full Text] [Related]

  • 6. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM.
    Eur J Immunol; 2010 Nov 17; 40(11):3150-60. PubMed ID: 20957750
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
    Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J.
    Cell Immunol; 2007 Jun 17; 247(2):72-84. PubMed ID: 17927969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
    Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4565-74. PubMed ID: 17671143
    [Abstract] [Full Text] [Related]

  • 14. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S.
    Clin Cancer Res; 2007 Oct 15; 13(20):6010-8. PubMed ID: 17947462
    [Abstract] [Full Text] [Related]

  • 15. Modulation of expression and function of Toll-like receptor 3 in A549 and H292 cells by histamine.
    Hou YF, Zhou YC, Zheng XX, Wang HY, Fu YL, Fang ZM, He SH.
    Mol Immunol; 2006 May 15; 43(12):1982-92. PubMed ID: 16406095
    [Abstract] [Full Text] [Related]

  • 16. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X, Li S, Meng M, Qian W, Xie W, Chen D, Zhai Z, Shu HB.
    Eur J Immunol; 2006 Jan 15; 36(1):199-206. PubMed ID: 16323247
    [Abstract] [Full Text] [Related]

  • 17. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
    Xu Y, Zhao Y, Huang H, Chen G, Wu X, Wang Y, Chang W, Zhu Z, Feng Y, Wu D.
    Br J Haematol; 2010 Sep 15; 150(5):543-53. PubMed ID: 20629663
    [Abstract] [Full Text] [Related]

  • 18. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
    Chiron D, Pellat-Deceunynck C, Maillasson M, Bataille R, Jego G.
    J Immunol; 2009 Oct 01; 183(7):4371-7. PubMed ID: 19734228
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells.
    Nakada E, Walley KR, Nakada T, Hu Y, von Dadelszen P, Boyd JH.
    Placenta; 2009 Sep 01; 30(9):774-9. PubMed ID: 19631980
    [Abstract] [Full Text] [Related]

  • 20. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways.
    Dogusan Z, García M, Flamez D, Alexopoulou L, Goldman M, Gysemans C, Mathieu C, Libert C, Eizirik DL, Rasschaert J.
    Diabetes; 2008 May 01; 57(5):1236-45. PubMed ID: 18223009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.